In the BioHarmony Drug Report Database
Plicamycin
Mithracin (plicamycin) is a small molecule pharmaceutical. Plicamycin was first approved as Mithracin on 1982-01-01. It is used to treat bcr-abl positive chronic myelogenous leukemia, extramammary paget disease, hypercalcemia, and testicular neoplasms in the USA.
Trade Name
|
Mithracin |
|---|---|
Common Name
|
plicamycin |
ChEMBL ID
|
CHEMBL1237054 |
Indication
|
bcr-abl positive chronic myelogenous leukemia, extramammary paget disease, hypercalcemia, testicular neoplasms |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)